search
Back to results

Spinal Cord Stimulation Versus Instrumentation for FBSS (PROMISE)

Primary Purpose

Failed Back Surgery Syndrome, SCS, Neuromodulation

Status
Recruiting
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Spinal Cord Stimulation
Spinal Fusion Surgery
Sponsored by
University Hospital Augsburg
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Failed Back Surgery Syndrome

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age ≥18 years
  • Symptomatic degenerative disc disease with LBP as a predominant symptom for at least 6 months following pervious surgery for disc herniation
  • ODI score at least 21
  • Correctly signed informed consent form

Exclusion Criteria:

  • Spinal stenosis resulting in spinal claudication or neurological deficits
  • Spinal Instability (> 3 mm Motion on dynamic Lumbar X-rays)
  • Major psychiatric disorder

Sites / Locations

  • University Hospital Augsburg Department of NeurosurgeryRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Spinal Cord Stimulation Device

Control - Lumbar Fusion surgery

Arm Description

The spinal cord stimulators WaveWriter AlphaTM (Boston Scientific) are designed to treat chronic back or leg pain by electrically stimulating the spinal cord. It is a well established worldwide licensed device. Percutaneous lead(-s) are implanted in the epidural space of the thoracic spine during the initial procedure. After discharge a trial phase is initiated and performed according to local preferences and standard of operations (SOPs). Patients are monitored for any complications and pain reduction. If a significant pain reduction (>50 % on the NRS scale for back pain) is achieved, the permanent implantable pulse generator (IPG) is implanted. Otherwise if the therapy remains non-beneficial throughout the trial phase, the leads will be explanted. Patients are allowed to crossover in the fusion group at any point of time.

The control group needs to represent the standard of care of current practice. Gold standard is lumbar fusion surgery [Resnik 2005]. Surgical instrumentation will be performed according to local preferences and SOPs. Safety and efficacy of these fusion techniques have been repeatedly proven

Outcomes

Primary Outcome Measures

Oswestry disability index / ODI
A patient reported outcome measure to rate pain and disability

Secondary Outcome Measures

Adverse events
Comparison of complication rates
SF36
Score to assess quality of life
EuroQOL 5D
Score to assess quality of life
hospital length of stay
Time measured in days, counting from the first day of hospitalization until the day of discharge of the hospitalization the surgical intervention was performed. If surgery is performed as staged procedure in two separate hospitalizations (SCS) both hospitalizations are counted as described above and days are summed up.
Crossover rates
Rates of crossover to another therapy arm
Pain medication
Amount of analgesics taken (drug, dose, mode of application)

Full Information

First Posted
April 25, 2022
Last Updated
April 13, 2023
Sponsor
University Hospital Augsburg
Collaborators
Boston Scientific Corporation
search

1. Study Identification

Unique Protocol Identification Number
NCT05466110
Brief Title
Spinal Cord Stimulation Versus Instrumentation for FBSS
Acronym
PROMISE
Official Title
sPinal coRd stimulatiOn coMpared With Lumbar InStrumEntation for Low Back Pain After Previous Lumbar Decompression (PROMISE): a Prospective Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
March 20, 2023 (Actual)
Primary Completion Date
November 2024 (Anticipated)
Study Completion Date
May 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital Augsburg
Collaborators
Boston Scientific Corporation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Low back pain affects people of all ages and has become the leading cause of living with disability worldwide. Patients, suffering from persistent pain after spinal surgery in the absence of any clear spinal pathology are defined of having a "failed back surgery syndrome (FBSS)" and treatment of FBSS remains a great controversy in the spinal community. Apart from conservative treatment, spinal fusion remains as therapeutic option. Furthermore, minimal invasive Neuromodulation techniques might be a promising alternative. Aim of this randomized interventional multi center study is to compare treatment success in FBSS patients with either spinal cord stimulation (SCS) or fusion surgery, 12 months after intervention according to the Oswestry Disability Index (ODI) and other scales and scores. Radiological and health economic outcome also will be analysed for thorough comparison of techniques. Additionally, the safety of the interventions needs to be compared.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Failed Back Surgery Syndrome, SCS, Neuromodulation, Spinal Cord Stimulation, Spinal Fusion, Low Back Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
84 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Spinal Cord Stimulation Device
Arm Type
Experimental
Arm Description
The spinal cord stimulators WaveWriter AlphaTM (Boston Scientific) are designed to treat chronic back or leg pain by electrically stimulating the spinal cord. It is a well established worldwide licensed device. Percutaneous lead(-s) are implanted in the epidural space of the thoracic spine during the initial procedure. After discharge a trial phase is initiated and performed according to local preferences and standard of operations (SOPs). Patients are monitored for any complications and pain reduction. If a significant pain reduction (>50 % on the NRS scale for back pain) is achieved, the permanent implantable pulse generator (IPG) is implanted. Otherwise if the therapy remains non-beneficial throughout the trial phase, the leads will be explanted. Patients are allowed to crossover in the fusion group at any point of time.
Arm Title
Control - Lumbar Fusion surgery
Arm Type
Active Comparator
Arm Description
The control group needs to represent the standard of care of current practice. Gold standard is lumbar fusion surgery [Resnik 2005]. Surgical instrumentation will be performed according to local preferences and SOPs. Safety and efficacy of these fusion techniques have been repeatedly proven
Intervention Type
Device
Intervention Name(s)
Spinal Cord Stimulation
Other Intervention Name(s)
SCS
Intervention Description
Epidural application of electrical current to the spinal cord
Intervention Type
Procedure
Intervention Name(s)
Spinal Fusion Surgery
Intervention Description
screw-rod system based spinal instrumentation
Primary Outcome Measure Information:
Title
Oswestry disability index / ODI
Description
A patient reported outcome measure to rate pain and disability
Time Frame
12 months after intervention
Secondary Outcome Measure Information:
Title
Adverse events
Description
Comparison of complication rates
Time Frame
12 months after intervention
Title
SF36
Description
Score to assess quality of life
Time Frame
12 months after intervention
Title
EuroQOL 5D
Description
Score to assess quality of life
Time Frame
12 months after intervention
Title
hospital length of stay
Description
Time measured in days, counting from the first day of hospitalization until the day of discharge of the hospitalization the surgical intervention was performed. If surgery is performed as staged procedure in two separate hospitalizations (SCS) both hospitalizations are counted as described above and days are summed up.
Time Frame
through study completion, an average of 2 years
Title
Crossover rates
Description
Rates of crossover to another therapy arm
Time Frame
12 months after intervention
Title
Pain medication
Description
Amount of analgesics taken (drug, dose, mode of application)
Time Frame
12 months after intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥18 years Symptomatic degenerative disc disease with LBP as a predominant symptom for at least 6 months following pervious surgery for disc herniation ODI score at least 21 Correctly signed informed consent form Exclusion Criteria: Spinal stenosis resulting in spinal claudication or neurological deficits Spinal Instability (> 3 mm Motion on dynamic Lumbar X-rays) Major psychiatric disorder
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ehab Shiban, MD
Phone
0049 / (0)821 / 400-2251
Email
ehab.shiban@uk-augsburg.de
First Name & Middle Initial & Last Name or Official Title & Degree
Philipp Krauss, MD
Phone
0049 / (0)821 / 400-2251
Email
philippemanuel.krauss@uk-augsburg.de
Facility Information:
Facility Name
University Hospital Augsburg Department of Neurosurgery
City
Augsburg
State/Province
Bavaria
ZIP/Postal Code
86156
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ehab Shiban, MD
Email
Ehab.shiban@uk-augsburg.de
First Name & Middle Initial & Last Name & Degree
Philipp Krauss, MD
Email
philippemanuel.krauss@uk-augsburg.de

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
16028738
Citation
Resnick DK, Choudhri TF, Dailey AT, Groff MW, Khoo L, Matz PG, Mummaneni P, Watters WC 3rd, Wang J, Walters BC, Hadley MN; American Association of Neurological Surgeons/Congress of Neurological Surgeons. Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 10: fusion following decompression in patients with stenosis without spondylolisthesis. J Neurosurg Spine. 2005 Jun;2(6):686-91. doi: 10.3171/spi.2005.2.6.0686.
Results Reference
background
PubMed Identifier
12973134
Citation
Brox JI, Sorensen R, Friis A, Nygaard O, Indahl A, Keller A, Ingebrigtsen T, Eriksen HR, Holm I, Koller AK, Riise R, Reikeras O. Randomized clinical trial of lumbar instrumented fusion and cognitive intervention and exercises in patients with chronic low back pain and disc degeneration. Spine (Phila Pa 1976). 2003 Sep 1;28(17):1913-21. doi: 10.1097/01.BRS.0000083234.62751.7A.
Results Reference
background
PubMed Identifier
11725230
Citation
Fritzell P, Hagg O, Wessberg P, Nordwall A; Swedish Lumbar Spine Study Group. 2001 Volvo Award Winner in Clinical Studies: Lumbar fusion versus nonsurgical treatment for chronic low back pain: a multicenter randomized controlled trial from the Swedish Lumbar Spine Study Group. Spine (Phila Pa 1976). 2001 Dec 1;26(23):2521-32; discussion 2532-4. doi: 10.1097/00007632-200112010-00002.
Results Reference
background
PubMed Identifier
18287602
Citation
Weinstein JN, Tosteson TD, Lurie JD, Tosteson AN, Blood E, Hanscom B, Herkowitz H, Cammisa F, Albert T, Boden SD, Hilibrand A, Goldberg H, Berven S, An H; SPORT Investigators. Surgical versus nonsurgical therapy for lumbar spinal stenosis. N Engl J Med. 2008 Feb 21;358(8):794-810. doi: 10.1056/NEJMoa0707136.
Results Reference
background
PubMed Identifier
26218762
Citation
Kapural L, Yu C, Doust MW, Gliner BE, Vallejo R, Sitzman BT, Amirdelfan K, Morgan DM, Brown LL, Yearwood TL, Bundschu R, Burton AW, Yang T, Benyamin R, Burgher AH. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. Anesthesiology. 2015 Oct;123(4):851-60. doi: 10.1097/ALN.0000000000000774.
Results Reference
background
PubMed Identifier
11074683
Citation
Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000 Nov 15;25(22):2940-52; discussion 2952. doi: 10.1097/00007632-200011150-00017.
Results Reference
background
PubMed Identifier
34705106
Citation
Achttien RJ, Powell A, Zoulas K, Staal JB, Rushton A. Prognostic factors for outcome following lumbar spine fusion surgery: a systematic review and narrative synthesis. Eur Spine J. 2022 Mar;31(3):623-668. doi: 10.1007/s00586-021-07018-5. Epub 2021 Oct 27.
Results Reference
background

Learn more about this trial

Spinal Cord Stimulation Versus Instrumentation for FBSS

We'll reach out to this number within 24 hrs